Published June 1992 | Version v1
Report Restricted

Nuclear medicine and imaging research (quantitative studies in radiopharmaceutical science)

Description

This report describes three studies aimed at using radiolabeled pharmaceuticals to explore brain function and anatomy. The first section describes the chemical preparation of [F18]fluorinated benzamides (dopamine D-2 receptor tracers), [F18]fluorinated benzazepines (dopamine D-1 receptor tracers), and tissue distribution of [F18]-fluoxetine (serotonin reuptake site tracer). The second section relates pharmacological and behavioral studies of amphetamines. The third section reports on progress made with processing of brain images from CT, MRI and PET/SPECT with regards to brain metabolism of glucose during mental tasks

Availability note (English)

MF available from INIS under the Report Number; OSTI as DE92016969; NTIS; INIS; US Govt. Printing Office Dep.

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Additional details

Additional titles

Subtitle (English)
Progress report, January 1, 1992--December 31, 1992

Publishing Information

Imprint Pagination
22 p.
Report number
DOE/ER/60438--4

Optional Information

Contract/Grant/Project number
Contract FG02-86ER60438
Funding organization
USDOE, Washington, DC (United States).